MIRM

74.42

2.32% -1.77

Dopo l'orario di chiusura: 74.42

Mirum Pharmaceuticals Inc (MIRM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché MIRM Giù? Forum Previsione

Precedente Chiudi:

$76.19

Aprire:

$76.77

Volume 24 ore:

350.23K

Relative Volume:

0.49

Capitalizzazione di mercato:

$3.74B

Reddito:

$379.25M

Utile/perdita netta:

$-77.34M

Rapporto P/E:

-46.16

EPS:

-1.6122

Flusso di cassa netto:

$-27.87M

1 W Prestazione:

+0.81%

1M Prestazione:

+0.85%

6M Prestazione:

+92.05%

1 anno Prestazione:

+87.08%

Intervallo 1D:

$74.39

$77.00

Intervallo di 1 settimana:

$71.43

$77.00

Portata 52W:

$36.88

$78.54

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Nome

Mirum Pharmaceuticals Inc

Settore

Healthcare (1140)

Industria

Biotechnology (637)

Telefono

650-667-4085

Indirizzo

989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY

Dipendente

349

Cinguettio

@mirumpharma

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

MIRM's Discussions on Twitter

Confronta MIRM con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MIRM Mirum Pharmaceuticals Inc	74.42	3.68B	379.25M	-77.34M	-27.87M	-1.6122
VRTX Vertex Pharmaceuticals Inc	408.61	105.69B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	481.07	61.52B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	569.17	60.69B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	837.28	50.05B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	318.02	35.25B	4.56B	-176.77M	225.30M	-1.7177

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-24	Iniziato	TD Cowen	Buy
2025-08-11	Ripresa	Stifel	Buy
2025-05-19	Ripresa	H.C. Wainwright	Buy
2024-04-17	Iniziato	Stifel	Buy
2023-12-18	Reiterato	H.C. Wainwright	Buy
2023-11-20	Ripresa	JP Morgan	Overweight
2023-11-13	Iniziato	Morgan Stanley	Overweight
2023-10-24	Iniziato	Cantor Fitzgerald	Overweight
2023-10-17	Ripresa	Evercore ISI	Outperform
2023-09-20	Iniziato	JMP Securities	Mkt Outperform
2022-09-01	Iniziato	Citigroup	Buy
2021-09-20	Iniziato	JP Morgan	Overweight
2020-08-07	Aggiornamento	Raymond James	Outperform → Strong Buy
2020-08-03	Iniziato	H.C. Wainwright	Buy
2020-07-31	Iniziato	Piper Sandler	Overweight
2020-06-25	Iniziato	Robert W. Baird	Outperform
2019-08-12	Iniziato	Citigroup	Buy
2019-08-12	Iniziato	Evercore ISI	Outperform
2019-08-12	Iniziato	Guggenheim	Buy
2019-08-12	Iniziato	ROTH Capital	Buy
2019-08-12	Iniziato	Raymond James	Outperform

Mostra tutto

Mirum Pharmaceuticals Inc Borsa (MIRM) Ultime notizie

06:04 AM

Is it time to cut losses on Mirum Pharmaceuticals Inc.Weekly Investment Recap & AI Optimized Trading Strategy Guides - newser.com

06:04 AM

04:02 AM

Technical signs of recovery in Mirum Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - newser.com

04:02 AM

06:18 AM

Mirum Pharmaceuticals (NASDAQ:MIRM) Is Carrying A Fair Bit Of Debt - simplywall.st

06:18 AM

Oct 15, 2025

How to build a custom watchlist for Mirum Pharmaceuticals Inc.Market Risk Report & Daily Stock Momentum Reports - newser.com

Oct 15, 2025

Is Mirum Pharmaceuticals Inc. stock supported by strong cash flows - newser.com

Oct 15, 2025

Oct 14, 2025

How to integrate Mirum Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com

Oct 14, 2025

Why Mirum Pharmaceuticals Inc. stock remains undervalued2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com

Oct 14, 2025

Will Livmarli Continue to Drive Mirum's Top Line in Q3 Earnings? - Yahoo Finance

Oct 14, 2025

Oct 13, 2025

How to use a screener to detect Mirum Pharmaceuticals Inc. breakoutsProduct Launch & Real-Time Chart Pattern Alerts - newser.com

Oct 13, 2025

Oct 12, 2025

Volume spikes in Mirum Pharmaceuticals Inc. stock – what they mean2025 Trade Ideas & Verified Short-Term Plans - newser.com

Oct 12, 2025

Oct 10, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Up 6.9%Should You Buy? - MarketBeat

Oct 10, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The AI Journal

Oct 10, 2025

Is Mirum Pharmaceuticals Inc. reversing from oversold territory2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com

Oct 10, 2025

Mirum Pharmaceuticals' (MIRM) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025

Can Mirum Pharmaceuticals Inc. (08D) stock survive global slowdownInflation Watch & Low Drawdown Investment Ideas - newser.com

Oct 10, 2025

Is Mirum Pharmaceuticals Inc 08D a good long term investmentRisk Management Strategies & Affordable Portfolio Trading - earlytimes.in

Oct 10, 2025

Will Mirum Pharmaceuticals Inc. rebound enough to break evenDollar Strength & Daily Profit Focused Screening - newser.com

Oct 10, 2025

Oct 09, 2025

Branded Website for Consumers 2025 - Medical Marketing and Media

Oct 09, 2025

Mirum Pharmaceuticals stock hits all-time high at 78.23 USD - Investing.com

Oct 09, 2025

Mirum Pharmaceuticals stock hits all-time high at 78.23 USD By Investing.com - Investing.com Australia

Oct 09, 2025

What data driven models say about Mirum Pharmaceuticals Inc.’s futureJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com

Oct 09, 2025

Will Mirum Pharmaceuticals Inc. stock recover faster than peersIndex Update & Risk Controlled Daily Trade Plans - newser.com

Oct 09, 2025

Oct 07, 2025